T0	Participants 108 170	stage I low-grade and intermediate-grade non-Hodgkin lymphoma.
T1	Participants 389 510	patients with Stage I non-Hodgkin lymphoma (NHL) who have achieved a complete response (CR) after radiation therapy (RT).
T2	Participants 519 610	Forty-four patients with clinical or pathologic Stage I intermediate-grade or low-grade NHL